Drug Profile


Alternative Names: INN 00835; Netamiftide

Latest Information Update: 02 Jun 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Innapharma
  • Developer Tetragenex Pharmaceuticals
  • Class Antidepressants; Oligopeptides
  • Mechanism of Action Serotonin 2A receptor antagonists; Serotonin plasma membrane transport protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Major depressive disorder

Most Recent Events

  • 29 Jul 2009 Nemifitide is available for licensing (
  • 08 Nov 2004 A study has been added to the adverse events and Affective disorders therapeutic trials sections
  • 07 Jul 2004 Data presented at the XXIVth Congress Collegium Internationale Neuro-Psychopharmacologicum (CINP-2004) have been added to the pharmacokinetics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top